Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Causes of symptom dissatisfaction in patients with generalized myasthenia gravis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prediagnosis epilepsy and survival in patients with glioma: a nationwide population-based cohort study from 2009 to 2018

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The levels of the serine protease HTRA1 in cerebrospinal fluid correlate with progression and disability in multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Frequency of fatigue and its changes in the first 6 months after traumatic brain injury: results from the CENTER-TBI study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. No effect of triheptanoin in patients with phosphofructokinase deficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Patient-centered assessments have attracted increasing attention in the last decade in clinics and research. The purpose of this study was to examine the association between patients' satisfaction with symptoms and several disease-specific and generic outcome measures in 100 patients with generalized myasthenia gravis (gMG).

METHODS: In this cross-sectional study, patients with gMG followed at the Copenhagen Neuromuscular Center from October 2019 to June 2020 participated in one test. The patients completed commonly used MG-specific outcome measures and generic questionnaires for depression (Major Depression Inventory), comorbidities (Charlson Comorbidity Index), fatigue (Multidimensional Fatigue Inventory), overall health state (EQ-5D-3L), and satisfaction with MG treatment. The analyses were anchored in the Patient Acceptable Symptom State (PASS).

RESULTS: N = 190 patients were screened for the study, and 100 patients were included. One-third of the patients reported dissatisfaction (negative PASS status) with the current symptom state. Increasing MG symptoms, fatigue, depression, low MG-related quality of life, and shorter disease duration were associated with negative PASS status. Age, sex, BMI, MG treatment, and comorbidity did not influence PASS status.

CONCLUSIONS: This study shows that dissatisfaction with the current symptom level is high in patients with gMG and that dissatisfaction is associated with disease severity, disease length, depression, fatigue, and lower MG-related quality of life. The results emphasize the importance of a patient-centered approach to MG treatment to optimize patient satisfaction. The PASS question was useful in this study to investigate the causes of symptom dissatisfaction in gMG.

Original languageEnglish
JournalJournal of Neurology
Volume269
Issue number6
Pages (from-to)3086-3093
Number of pages8
ISSN0340-5354
DOIs
Publication statusPublished - Jun 2022

Bibliographical note

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

    Research areas

  • Depression, Fatigue, Myasthenia gravis, Patient acceptance of health care, Patient outcome assessment

ID: 72649279